The Pros and Cons of Mesenchymal Stem Cell-Based Therapies

被引:295
|
作者
Musial-Wysocka, Aleksandra [1 ]
Kot, Marta [1 ]
Majka, Marcin [1 ]
机构
[1] Jagiellonian Univ, Dept Transplantat, Med Coll, Wielicka St 265, PL-30663 Krakow, Poland
关键词
mesenchymal stem cells; somatic cell therapy; transplantation; engraftment; immunomodulatory properties; HUMAN BONE-MARROW; VERSUS-HOST-DISEASE; SUPPRESS T-LYMPHOCYTE; STROMAL CELLS; UMBILICAL-CORD; ADIPOSE-TISSUE; EXTRACELLULAR VESICLES; MYOCARDIAL-INFARCTION; INTERNATIONAL-SOCIETY; INTRAVENOUS DELIVERY;
D O I
10.1177/0963689719837897
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The need to search for new, alternative treatments for various diseases has prompted scientists and physicians to focus their attention on regenerative medicine and broadly understood cell therapies. Currently, stem cells are being investigated for their potentially widespread use in therapies for many untreatable diseases. Nowadays modern treatment strategies willingly use mesenchymal stem cells (MSCs) derived from different sources. Researchers are increasingly aware of the nature of MSCs and new possibilities for their use. Due to their properties, especially their ability to self-regenerate, differentiate into several cell lineages and participate in immunomodulation, MSCs have become a promising tool in developing modern and efficient future treatment strategies. The great potential and availability of MSCs allow for their various clinical applications in the treatment of many incurable diseases. In addition to their many advantages and benefits, there are still questions about the use of MSCs. What are the mechanisms of action of MSCs? How do they reach their destination? Is the clinical use of MSCs safe? These are the main questions that arise regarding MSCs when they are considered as therapeutic tools. The diversity of MSCs, their different clinical applications, and their many traits that have not yet been thoroughly investigated are sources of discussions and controversial opinions about these cells. Here, we reviewed the current knowledge about MSCs in terms of their therapeutic potential, clinical effects and safety in clinical applications.
引用
收藏
页码:801 / 812
页数:12
相关论文
共 50 条
  • [41] Preventive therapies: Weighing the pros and cons
    Laupacis, A
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1996, 154 (10) : 1510 - 1512
  • [42] Pros and Cons of Cryopreserving Allogeneic Stem Cell Products
    Valentini, Caterina Giovanna
    Pellegrino, Claudio
    Teofili, Luciana
    [J]. CELLS, 2024, 13 (06)
  • [43] Pros and cons of stem cell transplantation for autoimmune disease
    Thomas, ED
    [J]. JOURNAL OF RHEUMATOLOGY, 1997, 24 : 100 - 102
  • [44] Clinical applications of stem cell therapy - the pros and cons of stem cell sources
    Habib, Nagy A.
    Gordon, M. Y.
    [J]. REGENERATIVE MEDICINE, 2006, 1 (03) : 301 - 302
  • [45] AUTOMATED APPROACHES FOR PROCESS DEVELOPMENT AND MANUFACTURE OF HUMAN MESENCHYMAL STEM CELLS FOR CELL-BASED THERAPIES
    Rafiq, Q. A.
    Nienow, A.
    Hewitt, C.
    [J]. CYTOTHERAPY, 2017, 19 (05) : S85 - S86
  • [46] Stem cell-based and mesenchymal stem cell derivatives for coronavirus treatment
    Rafiee, Zeinab
    Nejaddehbashi, Fereshteh
    Nasrolahi, Ava
    Moghadam, Fatemeh Khademi
    [J]. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2022, 69 (05) : 1942 - 1965
  • [47] Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges
    Masterson, C. H.
    Ceccato, A.
    Artigas, A.
    dos Santos, C.
    Rocco, P. R.
    Enes, S. Rolandsson
    Weiss, D. J.
    McAuley, D.
    Matthay, M. A.
    English, K.
    Curley, G. F.
    Laffey, J. G.
    [J]. INTENSIVE CARE MEDICINE EXPERIMENTAL, 2021, 9 (01)
  • [48] Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases
    Chenxia Hu
    Lingfei Zhao
    Lanjuan Li
    [J]. Stem Cell Research & Therapy, 10
  • [49] Old Friends with Unexploited Perspectives: Current Advances in Mesenchymal Stem Cell-Based Therapies in Asthma
    Marlena Tynecka
    Marcin Moniuszko
    Andrzej Eljaszewicz
    [J]. Stem Cell Reviews and Reports, 2021, 17 : 1323 - 1342
  • [50] Restoring the quantity and quality of elderly human mesenchymal stem cells for autologous cell-based therapies
    Travis J. Block
    Milos Marinkovic
    Olivia N. Tran
    Aaron O. Gonzalez
    Amanda Marshall
    David D. Dean
    Xiao-Dong Chen
    [J]. Stem Cell Research & Therapy, 8